BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lundstrom K. New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy. Biologics. 2018;12:43-60. [PMID: 29445265 DOI: 10.2147/btt.s140114] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Das R, Langou S, Le TT, Prasad P, Lin F, Nguyen TD. Electrical Stimulation for Immune Modulation in Cancer Treatments. Front Bioeng Biotechnol 2021;9:795300. [PMID: 35087799 DOI: 10.3389/fbioe.2021.795300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Chis AA, Dobrea CM, Rus LL, Frum A, Morgovan C, Butuca A, Totan M, Juncan AM, Gligor FG, Arseniu AM. Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy. Molecules 2021;26:5976. [PMID: 34641519 DOI: 10.3390/molecules26195976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Perez C, Rico J, Guerrero C, Acosta O. Role of heat-shock proteins in infection of human adenocarcinoma cell line MCF-7 by tumor-adapted rotavirus isolates. Colomb Med (Cali) 2021;52:e2024196. [PMID: 33911319 DOI: 10.25100/cm.v51i4.4196] [Reference Citation Analysis]
4 Franco-Luzón L, García-Mulero S, Sanz-Pamplona R, Melen G, Ruano D, Lassaletta Á, Madero L, González-Murillo Á, Ramírez M. Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient. Cancers (Basel) 2020;12:E1104. [PMID: 32354143 DOI: 10.3390/cancers12051104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Li L, Liu S, Han D, Tang B, Ma J. Delivery and Biosafety of Oncolytic Virotherapy. Front Oncol. 2020;10:475. [PMID: 32373515 DOI: 10.3389/fonc.2020.00475] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 14.7] [Reference Citation Analysis]
6 Hromic-Jahjefendic A, Lundstrom K. Viral Vector-Based Melanoma Gene Therapy. Biomedicines 2020;8:E60. [PMID: 32187995 DOI: 10.3390/biomedicines8030060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
7 Lauer UM, Yurttas C, Beil J. Novel Biological Therapies with Direct Application to the Peritoneal Cavity. Cancer Regional Therapy 2020. [DOI: 10.1007/978-3-030-28891-4_2] [Reference Citation Analysis]
8 Kwon S. The Trend in the Development of Oncolytic Virus Therapy. BSL 2019;25:201-210. [DOI: 10.15616/bsl.2019.25.3.201] [Reference Citation Analysis]
9 Taverner WK, Jacobus EJ, Christianson J, Champion B, Paton AW, Paton JC, Su W, Cawood R, Seymour LW, Lei-Rossmann J. Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation. Mol Ther Oncolytics 2019;15:117-30. [PMID: 31890865 DOI: 10.1016/j.omto.2019.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Song H, Zhong LP, He J, Huang Y, Zhao YX. Application of Newcastle disease virus in the treatment of colorectal cancer. World J Clin Cases 2019; 7(16): 2143-2154 [PMID: 31531310 DOI: 10.12998/wjcc.v7.i16.2143] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
11 Wu T, Xiang Y, Liu T, Wang X, Ren X, Ye T, Li G. Oncolytic Vaccinia Virus Expressing Aphrocallistes vastus Lectin as a Cancer Therapeutic Agent. Mar Drugs 2019;17:E363. [PMID: 31248066 DOI: 10.3390/md17060363] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
12 Lypova N, Lanceta L, Gibson A, Vega S, Garza-Morales R, McMasters KM, Chesney J, Gomez-Gutierrez JG, Imbert-Fernandez Y. Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy. Cancers (Basel) 2019;11:E684. [PMID: 31100952 DOI: 10.3390/cancers11050684] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
13 Sivanandam V, LaRocca CJ, Chen NG, Fong Y, Warner SG. Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds.Mol Ther Oncolytics. 2019;13:93-106. [PMID: 31080879 DOI: 10.1016/j.omto.2019.04.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 20.5] [Reference Citation Analysis]
14 Kim Y, Lee J, Lee D, Othmer HG. Synergistic Effects of Bortezomib-OV Therapy and Anti-Invasive Strategies in Glioblastoma: A Mathematical Model. Cancers (Basel) 2019;11:E215. [PMID: 30781871 DOI: 10.3390/cancers11020215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 Sitkovskaya AO, Zlatnik EY, Novikova IA, Kit OI. Newcastle disease virus - effective alliance in the fight against cancer. Sib onkol ž 2019;17:105-113. [DOI: 10.21294/1814-4861-2018-17-6-105-113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Lundstrom K. Self-Replicating RNA Viruses for RNA Therapeutics. Molecules 2018;23:E3310. [PMID: 30551668 DOI: 10.3390/molecules23123310] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
17 LaRocca CJ, Warner SG. Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials. Clin Transl Med 2018;7:35. [PMID: 30426287 DOI: 10.1186/s40169-018-0214-5] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 14.6] [Reference Citation Analysis]
18 Struzik J, Szulc-Dąbrowska L. NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses-Therapeutic Perspectives. Cancers (Basel) 2018;10:E426. [PMID: 30413032 DOI: 10.3390/cancers10110426] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
19 Lundstrom K. Viral Vectors in Gene Therapy. Diseases. 2018;6. [PMID: 29883422 DOI: 10.3390/diseases6020042] [Cited by in Crossref: 252] [Cited by in F6Publishing: 257] [Article Influence: 50.4] [Reference Citation Analysis]
20 Qu X, Tang Y, Hua S. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. Front Immunol. 2018;9:563. [PMID: 29662489 DOI: 10.3389/fimmu.2018.00563] [Cited by in Crossref: 155] [Cited by in F6Publishing: 159] [Article Influence: 31.0] [Reference Citation Analysis]